News
Hosted on MSN12m
South Africa Gets R520 Million to Buy the Twice-a-Year Anti-HIV Jab - But There's a SnagSA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year anti-HIV jab, lenacapavir ... much they're paying lenacapavir's maker, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback